Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Chemosphere ; 357: 142074, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38657693

RÉSUMÉ

The objective of this study was to assess the photolysis-mediated degradation of malathion in standard and commercial formulations, and to determine the toxicity of these degraded formulations. Degradation tests were carried out with 500 µg L-1 of malathion and repeated three times. The initial and residual toxicity was assessed by using Lactuca sativa seeds for phytotoxicity, Stegomyia aegypti larvae for acute toxicity, and Stegomyia aegypti mosquitoes (cultivated from the larval stage until emergence as mosquitoes) to evaluate the biochemical markers of sublethal concentrations. For the standard formulations the photolytic process efficiently reduced the initial concentration of malathion to levels below the regulatory limits however, the formation of byproducts was revealed by chromatography, which allowed for a more complete proposal of photolytic-mediated malathion degradation route. The degraded formulations inhibited the growth of L. sativa seeds, while only the untreated formulations showed larvicidal activity and mortality. Both formulations slightly inhibited acetylcholinesterase activity in S. aegypti mosquitoes, while the standard formulation decreased and the commercial formulation increased glutathione S-transferase activity. However, there were no significant differences for superoxide dismutase, esterase-α, esterase-ß and lipid peroxidation. These findings indicate that in the absence of the target compound, the presence of byproducts can alter the enzymatic activity. In general, photolysis effectively degrade malathion lower than the legislation values; however, longer treatment times must be evaluated for the commercial formulation.


Sujet(s)
Insecticides , Larve , Malathion , Photolyse , Malathion/composition chimique , Malathion/toxicité , Animaux , Insecticides/composition chimique , Insecticides/toxicité , Insecticides/pharmacologie , Larve/effets des médicaments et des substances chimiques , Aedes/effets des médicaments et des substances chimiques , Aedes/croissance et développement , Acetylcholinesterase/métabolisme , Écotoxicologie , Marqueurs biologiques/métabolisme , Lactuca/effets des médicaments et des substances chimiques , Glutathione transferase/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Superoxide dismutase/métabolisme
2.
Photochem Photobiol Sci ; 19(10): 1470-1477, 2020 Oct 14.
Article de Anglais | MEDLINE | ID: mdl-32857084

RÉSUMÉ

Of all cyanobacteria, Microcystis aeruginosa is the most commonly found species in bloom episodes all over the world. This species is known to produce cyanopeptides with hepatotoxic effects, namely microcystins (MCs). In this regard, Advanced Oxidation Processes (AOPs) have been widely studied for cyanotoxin degradation, but very few studies focused on cyanobacteria inactivation combined with toxin removal. To our knowledge, this is the first report of the photo-Fenton process application focusing on M. aeruginosa inactivation and microcystin-LR (MC-LR) degradation. This research work aimed to evaluate the photo-Fenton process under three different conditions with regard to Fe2+/H2O2 ratios (0.6/10, 5/50, and 20/100 mg L-1) at the initial near-neutral pH. Process efficiency was measured by immediate cell density reduction, growth inhibition, effect on MC-LR concentrations, and scanning electron microscopy (SEM) to analyze any alterations in cell morphology. Growth inhibition test (GIT) results pointed to cell inactivation under all conditions tested, and MC-LR concentrations were reduced below WHO's maximum limit at medium and higher concentrations of reagents. The possible mechanisms of cell inactivation by oxidative species are discussed.


Sujet(s)
Toxines de la flore et de la faune marines/métabolisme , Microcystines/métabolisme , Microcystis/métabolisme , Composés du fer II/analyse , Composés du fer II/pharmacologie , Peroxyde d'hydrogène/analyse , Peroxyde d'hydrogène/pharmacologie , Concentration en ions d'hydrogène , Microcystis/cytologie , Microcystis/effets des médicaments et des substances chimiques , Oxydoréduction
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE